Serum levels of soluble CD30 and total IgE in alcoholics

This publication has 26 references indexed in Scilit:

• Soluble cytokine receptor CD30 in atopic disorders: a case‐control study
  Clinical and Experimental Allergy, 1999
• In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells
  Journal of Leukocyte Biology, 1997
• Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
  Clinical Microbiology Reviews, 1996
• Serum levels of soluble CD30 in chronic hepatitis B virus infection
  Clinical and Experimental Immunology, 1996
• CD30 and type 2 T helper (Th2) responses
  Journal of Leukocyte Biology, 1995
• High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS
  AIDS, 1994
• Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis.
  Journal of Clinical Oncology, 1994
• Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T‐cell leukemia and infectious mononucleosis
  International Journal of Cancer, 1990
• Ki‐1 (CD30) antigen is released by Ki‐1‐positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki‐1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme‐linked immunosorbent assay
  European Journal of Immunology, 1989
• The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells
  Blood, 1985